Anti-Atherosclerotic Effect of Afrocyclamin A against Vascular Smooth Muscle Cells Is Mediated via p38 MAPK Signaling Pathway

(Pages: 191-198)
Yan Gu, M.M, 1,*Zhanzhan Xiao, B.Sc, 2Jianlie Wu, M.M, 3Mingjin Guo, M.D, 3Ping Lv, B.Sc, 4Ning Dou, M.M, 5
Department of Vascular Surgery, Tianjin First Center Hospital, Tianjin, China
Department of Emergency Services, The Fourth People’s Hospital of Jinan City, Jinan, Shandong Province, China
Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, China
Department of Hematology, The Fourth People’s Hospital of Jinan City, Jinan, Shandong Province, China
Department of General Surgery, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai, China
Department of Vascular Surgery, Tianjin First Center Hospital, Tianjin, China
Department of Emergency Services, The Fourth People’s Hospital of Jinan City, Jinan, Shandong Province, China
Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, China
Department of Hematology, The Fourth People’s Hospital of Jinan City, Jinan, Shandong Province, China
Department of General Surgery, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai, China
*Corresponding Address: Department of Vascular Surgery Tianjin First Center Hospital Tianjin China Email:18291939982@sina.com
The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gu Yan, Xiao Zhanzhan, Wu Jianlie, Guo Mingjin, Lv Ping, Dou Ning. Anti-Atherosclerotic Effect of Afrocyclamin A against Vascular Smooth Muscle Cells Is Mediated via p38 MAPK Signaling Pathway. Cell J. 2021; 23(2): 191-198.

Abstract

Objective

Research suggests that fine particulate matter (PM2.5) contributes to the expansion and development of atherosclerosis. Infiltration and proliferation of vascular smooth muscle cells (VSMCs) from the blood vessel media into the intima, is an important step in the atherosclerosis pathophysiology. Afrocyclamin A, is an oleanane-type triterpene saponin, isolated from Androsace umbellate, which is commonly used in Chinese herbal medicine. In the study, we examined the effect of Afrocyclamin A on PM2.5-induced VSMCs proliferation and scrutinized possible mechanisms of action.

Materials and Methods

In the experimental study, counting Kit-8 (CCK-8) assay was used for estimation of VSMCs viability. BrdU immunofluorescence was used for estimation of VSMCs proliferation. The levels of antioxidant parameters such as malonaldehyde (MDA), superoxide dismutase (SOD), and glutathione (GSH); proinflammatory cytokines such as interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), nitric oxide (NO), endothelin-1 (ET-1), and vascular cell adhesion molecule-1 (VCAM-1), were estimated. The expression of proliferating cell nuclear antigen (PCNA) and phospho-p38 MAPK (p-p38 MAPK) was assessed.

Results

Compared to PM2.5-treated cells, in addition to reducing PM2.5-induced VSMCs proliferation, Afrocyclamin A reduced the expression of PCNA and p-p38 MAPK, down-regulated the level of TNF-α, IL-1β, IL-6, VCAM-1, MDA and ET-1, and up-regulated SOD, GSH and NO level. Furthermore, the anti-proliferative effect of Afrocyclamin A was considerably increased following co-incubation of Afrocyclamin A with SB203580 (p38 MAPK inhibitor) in comparison with Afrocyclamin A-treated cells.

Conclusion

Based on the results, we can conclude that Afrocyclamin A might reduce PM2.5-induced VSMCs proliferation via reduction of p38 MAPK signaling pathway.